SCHEMBL7100954

SCHEMBL7100954

COc1cc(NN2CCCC2)cnc1Cl

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.46
CHRNA4 P43681 4/20 0.46
MAPT P10636 1/20 0.36
GRM5 P41594 1/20 0.36
CHRNB4 P30926 2/20 0.36
CHRNA3 P32297 2/20 0.36
CHRNA7 P36544 2/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
PIK3CG P48736 1/20 0.35
BRD4 O60885 3/20 0.34
PIK3CA P42336 2/20 0.34
MTOR P42345 1/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7105349 0.98 CHRNB2 (0.45) CHRNB2CHRNA4MAPTGRM5CHRNB4
Hydrochloric Acid SCHEMBL7482598 0.98 CHRNB2 (0.45) CHRNB2CHRNA4MAPTGRM5CHRNB4
SCHEMBL7481887 0.98 CHRNB2 (0.45) CHRNB2CHRNA4MAPTGRM5CHRNB4
SCHEMBL7102423 0.80 CHRNB2 (0.38) CHRNB2CHRNA4CHRNB4CHRNA3L3MBTL1
SCHEMBL7103269 0.79 ALDH1A1 (0.36) CHRNB2CHRNA4MAPTCHRNB4CHRNA3
Hydrochloric Acid SCHEMBL7487751 0.78 CHRNB2 (0.37) CHRNB2CHRNA4CHRNB4CHRNA3L3MBTL1
SCHEMBL7100981 0.78 CHRNB2 (0.37) CHRNB2CHRNA4MAPTGRM5CHRNB4
Hydrochloric Acid SCHEMBL7486498 0.78 CHRNB2 (0.37) CHRNB2CHRNA4CHRNB4CHRNA3L3MBTL1
SCHEMBL7098002 0.78 CHRNB2 (0.37) CHRNB2CHRNA4MAPTGRM5CHRNB4
SCHEMBL7101903 0.78 METAP2 (0.32) MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003500402-A 2003-01-07 JP claimed
CN-1361774-A Heterocyclic substituted amino nitrogen heterocycles as central nervous system medicaments ABBOTT INC (US) 2002-07-31 CN claimed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 EP claimed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 WO claimed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 EP disclosed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 WO disclosed